retatrutide trial phase Retatrutide Before and After: Doctor Reveals Real Results

Today we shared new results on retatrutide, an investigational, first-of-its-kind treatment we're studying in adults with obesity or overweight with at least one weight-related comorbidity. Read more about the Phase 3 findings:

23.91

★★★★☆4.8 (126)

Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial

20.37

★★★★★4.9 (98)

A waterfall graph from the phase 2 trial with retatrutide showing the

27.40

★★★★★5.0 (157)

The numbers from Lilly's Phase 3 retatrutide trial dropped this week and I haven't been able to stop thinking about them. Not only as a doctor but as a long-term GLP-1 user

20.93

★★★★★4.7 (84)

Looking forward to when #retatrutide's Phase 3 trial results will become available. There are are 4 planned TRIUMPH trials investigating retatrutide's efficacy in treating obesity and its complications: #type2diabetes #cardiovascular disease

29.28

★★★★★4.9 (203)

New Weight Loss Drug Retatrutide: My Patient's 85-Pound Journey (And What the Trials Don't Tell You)

25.41

★★★★★5.0 (176)

Retatrutide, the next generation of GLP-1 drug from Eli Lilly, helped participants lose an average of 71.2 pounds and reduce knee arthritis pain in a late-stage clinical trial, the company announced

27.79

★★★★★4.8 (132)